# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009672
Filing Date
2020-08-06
Accepted
2020-08-06 16:22:11
Documents
93
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20200630x10q.htm iXBRL | 10-Q | 2046971
2 | EX-31.1 | tmb-20200630xex31d1.htm | EX-31.1 | 9711
3 | EX-31.2 | tmb-20200630xex31d2.htm | EX-31.2 | 9759
4 | EX-32.1 | tmb-20200630xex32d1.htm | EX-32.1 | 7935
| Complete submission text file | 0001558370-20-009672.txt |  | 9088105

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20200630.xsd | EX-101.SCH | 89568
6 | EX-101.CAL | tmb-20200630_cal.xml | EX-101.CAL | 53612
7 | EX-101.DEF | tmb-20200630_def.xml | EX-101.DEF | 344964
8 | EX-101.LAB | tmb-20200630_lab.xml | EX-101.LAB | 570263
9 | EX-101.PRE | tmb-20200630_pre.xml | EX-101.PRE | 570029
10 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20200630x10q_htm.xml | XML | 1513391

Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 201082036
SIC: 2834 Pharmaceutical Preparations